Business Description
Avecho Biotechnology Ltd
ISIN : AU0000047441
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.7 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -45.57 | |||||
Beneish M-Score | -6.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 84.61 | |||||
9-Day RSI | 68.79 | |||||
14-Day RSI | 62.12 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -42.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 3.48 | |||||
Cash Ratio | 3.04 | |||||
Days Inventory | 81.03 | |||||
Days Sales Outstanding | 352.91 | |||||
Days Payable | 530.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.6 | |||||
Shareholder Yield % | -57.03 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 0.8 | |||||
Operating Margin % | -1000.2 | |||||
Net Margin % | -699.6 | |||||
FCF Margin % | -684.34 | |||||
ROE % | -81.72 | |||||
ROA % | -61.1 | |||||
ROIC % | -441.58 | |||||
ROC (Joel Greenblatt) % | -1099.58 | |||||
ROCE % | -79.59 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4 | |||||
EV-to-EBIT | -2.32 | |||||
EV-to-EBITDA | -2.42 | |||||
EV-to-Revenue | 16.18 | |||||
EV-to-FCF | -1.44 | |||||
Earnings Yield (Greenblatt) % | -43.03 | |||||
FCF Yield % | -26.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avecho Biotechnology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.498 | ||
EPS (TTM) (A$) | -0.001 | ||
Beta | 1.64 | ||
Volatility % | 136.19 | ||
14-Day RSI | 62.12 | ||
14-Day ATR (A$) | 0.000507 | ||
20-Day SMA (A$) | 0.00335 | ||
12-1 Month Momentum % | -42.86 | ||
52-Week Range (A$) | 0.001 - 0.005 | ||
Shares Outstanding (Mil) | 3,169.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avecho Biotechnology Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avecho Biotechnology Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Avecho Biotechnology Ltd Frequently Asked Questions
What is Avecho Biotechnology Ltd(ASX:AVE)'s stock price today?
When is next earnings date of Avecho Biotechnology Ltd(ASX:AVE)?
Does Avecho Biotechnology Ltd(ASX:AVE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |